{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T08:24:29Z","timestamp":1787387069869,"version":"build-2736575974"},"reference-count":58,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/501100020884","name":"Agencia Nacional de Investigaci\u00f3n y Desarrollo","doi-asserted-by":"publisher","award":["ANID Becas\/Doctorado Nacional\/2019-21191251"],"award-info":[{"award-number":["ANID Becas\/Doctorado Nacional\/2019-21191251"]}],"id":[{"id":"10.13039\/501100020884","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Medicine Access"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Access to medicines remains a persistent global challenge. In Chile, several policies have sought to strengthen pharmaceutical coverage within the health system. Among them, the Explicit Health Guarantees (GES) and the Pharmacy Fund (FOFAR) represent major policy milestones.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study assesses the impact of GES and FOFAR on access to medicines for diabetes, dyslipidemia, and hypertension among beneficiaries of both public and private subsystems.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>A contribution analysis approach was applied using a mixed-methods design.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Quantitative analyses combined descriptive and quasi-experimental difference-in-differences methods based on repeated cross-sectional data from national health surveys (2003, 2009\/10, 2016\/17), focusing on medicine use and effective coverage. The qualitative component included ten semi-structured interviews with key informants involved in policy design and implementation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Results show that both GES and FOFAR substantially contributed to improving access to medicines for hypertension, diabetes, and dyslipidemia. Quantitative findings revealed marked increases in medicine use and effective coverage, particularly between 2010 and 2017, while qualitative evidence highlighted their complementary and reinforcing policy roles.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Taken together, our findings suggest that GES and FOFAR were likely important contributors to improvements in contact coverage and effective coverage for these chronic conditions in Chile, although these changes occurred alongside ongoing health-system strengthening efforts and should therefore be interpreted accordingly. Overall, incorporating medicines into social protection schemes\u2014especially through enforceable guarantees\u2014plays a key role in expanding access. Sustained impact requires adequate resources, robust logistics, and strong implementation capacity for chronic disease management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/27550834261480357","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T10:00:26Z","timestamp":1787220026000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Contribution analysis of drug coverage policies on access to medicines for diabetes, dyslipidemia and hypertension in Chile"],"prefix":"10.1177","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6004-5882","authenticated-orcid":false,"given":"Carla","family":"Castillo-Laborde","sequence":"first","affiliation":[{"name":"Universidad del Desarrollo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Arteaga","sequence":"additional","affiliation":[{"name":"University of Chile"},{"name":"Center for Cancer Prevention and Control (CECAN)"},{"name":"ANID FONDAP, University of Chile-Pontificia, Universidad Cat\u00f3lica de Chile, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"key":"e_1_3_8_2_2","volume-title":"Access to Medicines: Making Market Forces Serve the Poor","author":"WHO","year":"2017","unstructured":"WHO. Access to Medicines: Making Market Forces Serve the Poor. The Years in Public Health 2007-2017, 2017."},{"key":"e_1_3_8_3_2","first-page":"90","volume-title":"La Ruta del Medicamento en Chile","author":"Hirmas Adauy M","year":"2022","unstructured":"Hirmas Adauy M, Awad Avenda\u00f1o C. Modalidades de acceso a los medicamentos por parte de los pacientes. In: Castillo-Laborde C, Matute I, Aguilera X (eds). La Ruta del Medicamento en Chile. (CEPS, Facultad de Medicina CAS-UDD), 2022, pp. 90\u2013105."},{"key":"e_1_3_8_4_2","volume-title":"Programa de Gobierno: Para Crecer Con Igualdad (Ricardo Lagos 2000-2006)","author":"Lagos R","year":"1999","unstructured":"Lagos R. Programa de Gobierno: Para Crecer Con Igualdad (Ricardo Lagos 2000-2006). Impresos Universitaria S.A., 1999."},{"key":"e_1_3_8_5_2","volume-title":"Programa de Gobierno 2006 - 2010","author":"Bachelet M","year":"2005","unstructured":"Bachelet M. Programa de Gobierno 2006 - 2010. Estoy Contigo, 2005."},{"key":"e_1_3_8_6_2","volume-title":"Programa de Gobierno Michelle Bachelet 2014-2018","author":"Bachelet M","year":"2013","unstructured":"Bachelet M. Programa de Gobierno Michelle Bachelet 2014-2018. Chile de Todos, 2013."},{"key":"e_1_3_8_7_2","volume-title":"Programa de Gobierno 2018 - 2022","author":"Pi\u00f1era S","year":"2017","unstructured":"Pi\u00f1era S. Programa de Gobierno 2018 - 2022. Construyamos Tiempos Mejores Para Chile, 2017."},{"key":"e_1_3_8_8_2","volume-title":"Programa de Gobierno para el cambio, el futuro y la esperanza. Chile 2010-2014","author":"Pi\u00f1era S","year":"2009","unstructured":"Pi\u00f1era S. Programa de Gobierno para el cambio, el futuro y la esperanza. Chile 2010-2014. Coalici\u00f3n por el Cambio.2009."},{"key":"e_1_3_8_9_2","volume-title":"Programa de Gobierno Apruebo Dignidad","author":"Boric G","year":"2021","unstructured":"Boric G. Programa de Gobierno Apruebo Dignidad. Boric Presidente, Apruebo Dignidad, 2021."},{"key":"e_1_3_8_10_2","unstructured":"Ministerio de Salud. Ley 19966. Establece Un R\u00e9gimen de Garant\u00edas Expl\u00edcitas 2004."},{"key":"e_1_3_8_11_2","unstructured":"Ministerio de Salud. Ley 20.724. Modifica El C\u00f3digo Sanitario En Materia de Regulaci\u00f3n de Farmacias y Medicamentos 2014."},{"key":"e_1_3_8_12_2","volume-title":"Fondo de Farmacia","author":"Ministerio de Salud","year":"2018","unstructured":"Ministerio de Salud. Fondo de Farmacia. FOFAR, 2018. https:\/\/www.minsal.cl\/fofar\/"},{"key":"e_1_3_8_13_2","unstructured":"Ministerio de salud. Ley 20850. Crea Un Sistema de Protecci\u00f3n Financiera Para Diagn\u00f3sticos y Tratamientos de Alto Costo y Rinde Homenaje P\u00f3stumo a Don Luis Ricarte Soto Gallegos 2015."},{"key":"e_1_3_8_14_2","unstructured":"Ministerio de Salud. GES. https:\/\/auge.minsal.cl\/ (2024)."},{"key":"e_1_3_8_15_2","doi-asserted-by":"publisher","DOI":"10.11565\/arsmed.v43i1.1354"},{"key":"e_1_3_8_16_2","unstructured":"Ferrer-Lues M Daigre ML Valdes I. Informe Final de Evaluaci\u00f3n de Programas Gubernamentales (EPG): Programa Fondo de Farmacia Para Enfermedades Cr\u00f3nicas No Transmisibles En Atenci\u00f3n Primaria de Salud 2014."},{"key":"e_1_3_8_17_2","volume-title":"Designing and Conducting Mixed Methods Research","author":"Cresswell J","year":"2017","unstructured":"Cresswell J, Plano Clark V. Designing and Conducting Mixed Methods Research. Sage Publications, 2017."},{"key":"e_1_3_8_18_2","volume-title":"Mixed Methodology. Combining Qualitative and Quantitative Approaches","author":"Tashakkori A","year":"1998","unstructured":"Tashakkori A, Teddlie C. Mixed Methodology. Combining Qualitative and Quantitative Approaches. Sage Publications. International Educational and Professional Publisher, 1998."},{"key":"e_1_3_8_19_2","doi-asserted-by":"publisher","DOI":"10.3138\/cjpe.016.001"},{"key":"e_1_3_8_20_2","first-page":"1","volume-title":"Contribution analysis: an approach to exploring cause and effect","author":"Mayne J","year":"2008","unstructured":"Mayne J. Contribution analysis: an approach to exploring cause and effect. Institutional Learning and Change Brief, 2008, pp. 1\u20134."},{"key":"e_1_3_8_21_2","volume-title":"M. Evaluation of PEPFAR\u2019s Contribution (2012-2017) to Rwanda\u2019s Human Resources for Health Program","author":"National Academies of Sciences, E","year":"2020","unstructured":"National Academies of Sciences, E. M. Evaluation of PEPFAR\u2019s Contribution (2012-2017) to Rwanda\u2019s Human Resources for Health Program. National Academies Press, 2020. https:\/\/doi.org\/10.17226\/25687"},{"key":"e_1_3_8_22_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-020-09483-x"},{"key":"e_1_3_8_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)01330-1"},{"key":"e_1_3_8_24_2","first-page":"295","article-title":"Health service coverage and its evaluation","volume":"56","author":"Tanahashi T","year":"1978","unstructured":"Tanahashi T. Health service coverage and its evaluation. Bull. World Health Organ 1978; 56: 295\u2013303.","journal-title":"Bull. World Health Organ"},{"key":"e_1_3_8_25_2","doi-asserted-by":"publisher","DOI":"10.1596\/978-1-4648-0779-4"},{"key":"e_1_3_8_26_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-publhealth-040617-013507"},{"key":"e_1_3_8_27_2","unstructured":"Ministerio de Salud. Resultados I Encuesta de Salud Chile 2003."},{"key":"e_1_3_8_28_2","unstructured":"Ministerio de Salud. Encuesta Nacional de Salud. Chile 2009-2010 Informe Final. Tomo I. Resumen Ejecutivo y Equipo de Trabajo 2010."},{"key":"e_1_3_8_29_2","volume-title":"Departamento de Epidemiolog\u00eda, Divisi\u00f3n de Planificaci\u00f3n Sanitaria, Subsecretar\u00eda de Salud P\u00fablica 61","author":"Ministerio de Salud","year":"2017","unstructured":"Ministerio de Salud. Encuesta Nacional de Salud 2016-2017 Primeros resultados. Departamento de Epidemiolog\u00eda, Divisi\u00f3n de Planificaci\u00f3n Sanitaria, Subsecretar\u00eda de Salud P\u00fablica 61, 2017."},{"key":"e_1_3_8_30_2","volume-title":"Departamento de Epidemiolog\u00eda, Divisi\u00f3n de Planificaci\u00f3n Sanitaria, Subsecretar\u00eda de Salud P\u00fablica","author":"Ministerio de Salud","year":"2018","unstructured":"Ministerio de Salud. Encuesta nacional de salud 2016-2017 Segunda entrega de resultados. In: Departamento de Epidemiolog\u00eda, Divisi\u00f3n de Planificaci\u00f3n Sanitaria, Subsecretar\u00eda de Salud P\u00fablica, 2018."},{"key":"e_1_3_8_31_2","volume-title":"Analysing Change over Time: Repeated Cross Sectional and Longitudinal Survey Data","author":"Rafferty A","year":"2015","unstructured":"Rafferty A, Walthery P, King-Hele S. Analysing Change over Time: Repeated Cross Sectional and Longitudinal Survey Data. UK Data Service, University of Essex and University of Manchester, 2015."},{"key":"e_1_3_8_32_2","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000003501"},{"key":"e_1_3_8_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2019.08.019"},{"key":"e_1_3_8_34_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-024-11900-5"},{"key":"e_1_3_8_35_2","unstructured":"ATLAS. ti Scientific Software Development. Atlas.ti 2021. Version 9.1.2. Preprint at."},{"key":"e_1_3_8_36_2","doi-asserted-by":"publisher","DOI":"10.4135\/9781452230153"},{"key":"e_1_3_8_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/1475-6773.12117"},{"key":"e_1_3_8_38_2","volume-title":"Health at a Glance 2015 OECD Indicators","author":"Organisation for Economic Co-operation and Development","year":"2015","unstructured":"Organisation for Economic Co-operation and Development. Health at a Glance 2015 OECD Indicators. OECD Publishing, 2015. https:\/\/doi.org\/10.1787\/health_glance-2013-en"},{"key":"e_1_3_8_39_2","doi-asserted-by":"crossref","unstructured":"OECD. Health at a Glance 2017 OECD Indicators 2017. https:\/\/doi.org\/10.1787\/health_glance-2017-en","DOI":"10.1787\/health_glance-2017-en"},{"key":"e_1_3_8_40_2","doi-asserted-by":"publisher","DOI":"10.1080\/16549716.2018.1434935"},{"key":"e_1_3_8_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2014.08.410"},{"key":"e_1_3_8_42_2","doi-asserted-by":"publisher","DOI":"10.1093\/heapol\/czv083"},{"key":"e_1_3_8_43_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-51673-8"},{"key":"e_1_3_8_44_2","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.18.222448"},{"key":"e_1_3_8_45_2","unstructured":"Ministerio de Salud de Argentina. Impacto Redistributivo Del Programa Remediar En El Gasto En Medicamentos. Estudio Cuantitativo de Impacto Sobre La Equidad 2013."},{"key":"e_1_3_8_46_2","first-page":"1","article-title":"Access to medicines for diabetes treatment in Brazil: evaluation of \u201chealth has no price \u201d program","volume":"8","author":"Oliveira Araujo J","year":"2016","unstructured":"Oliveira Araujo J, Pereira MD, de C\u00e1ssia Bergamaschi C, et al. Access to medicines for diabetes treatment in Brazil: evaluation of \u201chealth has no price \u201d program. Diabetol. Metab. Syndr 2016; 8: 1\u20135. https:\/\/doi.org\/10.1186\/s13098-016-0150-8","journal-title":"Diabetol. Metab. Syndr"},{"key":"e_1_3_8_47_2","doi-asserted-by":"publisher","DOI":"10.37757\/MR2017.V19.N2-3.10"},{"key":"e_1_3_8_48_2","unstructured":"Superintendencia de salud. Cobertura Del Examen de Medicina Preventiva (EMP) En El Sistema Isapre Entre Julio 2017 y Junio 2018 2020."},{"key":"e_1_3_8_49_2","doi-asserted-by":"publisher","DOI":"10.1177\/1077558704273806"},{"key":"e_1_3_8_50_2","doi-asserted-by":"publisher","DOI":"10.1093\/heapol\/czv136"},{"key":"e_1_3_8_51_2","doi-asserted-by":"publisher","DOI":"10.2165\/00115677-200210070-00003"},{"key":"e_1_3_8_52_2","doi-asserted-by":"publisher","DOI":"10.3389\/phrs.2022.1604796"},{"key":"e_1_3_8_53_2","volume-title":"Investing in Medication Adherence Improves Health Outcomes and Health System Efficiency: Adherence to Medicines for Diabetes, Hypertension and Hyperlipidaemia","author":"Khan R","year":"2018","unstructured":"Khan R, Socha-Dietrich K. Investing in Medication Adherence Improves Health Outcomes and Health System Efficiency: Adherence to Medicines for Diabetes, Hypertension and Hyperlipidaemia. OECD Health Working Papers, 2018."},{"key":"e_1_3_8_54_2","doi-asserted-by":"publisher","DOI":"10.4067\/S0718-85602013000200001"},{"key":"e_1_3_8_55_2","doi-asserted-by":"publisher","DOI":"10.4067\/S0034-98872015000500003"},{"key":"e_1_3_8_56_2","volume-title":"Determinaci\u00f3n de la adherencia terap\u00e9utica y factores asociados, en pacientes cr\u00f3nicos inscritos en el Centro de Salud Familiar G\u00f3mez Carre\u00f1o","author":"Iba\u00f1ez Alcayaga C","year":"2018","unstructured":"Iba\u00f1ez Alcayaga C. Determinaci\u00f3n de la adherencia terap\u00e9utica y factores asociados, en pacientes cr\u00f3nicos inscritos en el Centro de Salud Familiar G\u00f3mez Carre\u00f1o. Universidad Andr\u00e9s Bello, 2018."},{"key":"e_1_3_8_57_2","first-page":"238","article-title":"Adherencia al tratamiento farmacol\u00f3gico y relaci\u00f3n con el control metab\u00f3lico en pacientes con DM2","volume":"14","author":"L\u00f3pez G","year":"2010","unstructured":"L\u00f3pez G, Felipe J, Moya P, et al. Adherencia al tratamiento farmacol\u00f3gico y relaci\u00f3n con el control metab\u00f3lico en pacientes con DM2. Revista Chilena de Salud P\u00fablica 2010; 14: 238\u2013270.","journal-title":"Revista Chilena de Salud P\u00fablica"},{"key":"e_1_3_8_58_2","first-page":"73","article-title":"Adherencia al tratamiento farmacol\u00f3gico en adultos mayores diab\u00e9ticos tipo 2 y sus factores asociados","volume":"28","author":"Bello Escamilla N","year":"2016","unstructured":"Bello Escamilla N, Montoya Caceres PA. Adherencia al tratamiento farmacol\u00f3gico en adultos mayores diab\u00e9ticos tipo 2 y sus factores asociados. Gerokomos 2016; 28: 73\u201377.","journal-title":"Gerokomos"},{"key":"e_1_3_8_59_2","unstructured":"WHO. Cardiovascular diseases. https:\/\/www.who.int\/health-topics\/cardiovascular-diseases#tab=tab_1"}],"container-title":["The Journal of Medicine Access"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/27550834261480357","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/27550834261480357","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/27550834261480357","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T08:16:12Z","timestamp":1787386572000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/27550834261480357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":58,"alternative-id":["10.1177\/27550834261480357"],"URL":"https:\/\/doi.org\/10.1177\/27550834261480357","relation":{},"ISSN":["2755-0834","2755-0834"],"issn-type":[{"value":"2755-0834","type":"print"},{"value":"2755-0834","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8]]},"article-number":"27550834261480357"}}